China's Alwin Capital closes new dual-currency fund at $281m

The firm is focused on R&D, medical devices, molecular diagnostics, gene editing, and more.   

Related Keywords

China , Hong Kong , Shi Huijing , Guangdong , Abogen Biosciences , Sun Yana , Adlai Nortye , China International Capital Corporation , Asset Management Association Of China , Alwin Capital , Beijing Headquartered Alwin Capital , Asset Management Association , Matrix Partners China , Huigene Therapeutics ,